Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone

Australian Veterinary Practitioner

Volumn 34, Issue 4, 2004, Pages 161-162

  Nak, Deniz ^a   Nak, Yavuz ^a   Seyrek Intas, Kamil ^a   Kumru, Ismail Hakki ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGLEPRISTONE; ANTIGESTAGEN; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ARTICLE; BREAST FIBROADENOMA; CAT; CONTROLLED STUDY; ESTRUS; FEMALE; NONHUMAN; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TUMOR REGRESSION;

FELIDAE; FELIS CATUS;

EID: 13444256138     PISSN: 0310138X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. ARGYLE, DJ (1998) Manual of Small Animal Reproduction and Neonatology, Eds Simpson, England & Harvey, pp 53-59, British Small Animal Veterinary Association, UK
2. HOFFMANN, B & SCHULER, G (2000) Receptor blockers-general aspects with respect to their use in domestic animal reproduction, Anim Reproduct Sci 60:295
3. JOHNSTON, SD, KUSTRITZ, MVR & OLSON, PNS (2001) Canine and Feline Theriogenology, pp474-477, Saunders Philadelphia
4. GORLINGER, S, KOOISTRAHS, HS, VAN DEN BROEK, A & OKKENS AC (2002) Treatment of fibroadenomatous hyperplasia in cats with Aglepristone, J Vet Intern Med 16:710
5. MEISL, D, HUBLER, M, & ARNOLD, S (2003) Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in cat with the progesterone antagonist aglepristone (Alizine), Schweiz Arch Tierheilkd 145:130